SGEN

Seagen Inc

A biotechnology company that builds antibody-drug conjugates — cancer therapies that work like guided missiles, using antibodies to deliver cell-killing drugs straight to tumor cells. Founded in 1997 in Bothell, Washington as Seattle Genetics, it renamed itself Seagen in 2020, keeping the "SEA" from its Seattle roots. Its medicines include Adcetris, Padcev, Tukysa, and Tivdak, and Pfizer acquired the company in December 2023.

No Schedule 13D or 13G filings recorded.